Form 8-K - Current report:
SEC Accession No. 0001193125-25-006124
Filing Date
2025-01-14
Accepted
2025-01-14 16:02:16
Documents
43
Period of Report
2025-01-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d918233d8k.htm   iXBRL 8-K 34084
2 EX-99.1 d918233dex991.htm EX-99.1 23103
3 EX-99.2 d918233dex992.htm EX-99.2 42192
7 GRAPHIC g918233dsp005.jpg GRAPHIC 122691
8 GRAPHIC g918233dsp007.jpg GRAPHIC 228748
9 GRAPHIC g918233dsp008.jpg GRAPHIC 231724
10 GRAPHIC g918233dsp009.jpg GRAPHIC 221119
11 GRAPHIC g918233dsp010.jpg GRAPHIC 202869
12 GRAPHIC g918233dsp011.jpg GRAPHIC 251027
13 GRAPHIC g918233dsp012.jpg GRAPHIC 220303
14 GRAPHIC g918233dsp013.jpg GRAPHIC 240553
15 GRAPHIC g918233dsp014.jpg GRAPHIC 214777
16 GRAPHIC g918233dsp015.jpg GRAPHIC 217407
17 GRAPHIC g918233dsp016.jpg GRAPHIC 223358
18 GRAPHIC g918233dsp017.jpg GRAPHIC 237735
19 GRAPHIC g918233dsp018.jpg GRAPHIC 94209
20 GRAPHIC g918233dsp019.jpg GRAPHIC 209214
21 GRAPHIC g918233dsp020.jpg GRAPHIC 162794
22 GRAPHIC g918233dsp021.jpg GRAPHIC 172094
23 GRAPHIC g918233dsp022.jpg GRAPHIC 213179
24 GRAPHIC g918233dsp023.jpg GRAPHIC 174393
25 GRAPHIC g918233dsp024.jpg GRAPHIC 204771
26 GRAPHIC g918233dsp025.jpg GRAPHIC 179586
27 GRAPHIC g918233dsp026.jpg GRAPHIC 195234
28 GRAPHIC g918233dsp027.jpg GRAPHIC 221295
29 GRAPHIC g918233dsp028.jpg GRAPHIC 207684
30 GRAPHIC g918233dsp029.jpg GRAPHIC 73519
31 GRAPHIC g918233g0113215614592.jpg GRAPHIC 3519
32 GRAPHIC g918233g03f00.jpg GRAPHIC 533922
33 GRAPHIC g918233g04k00.jpg GRAPHIC 256212
34 GRAPHIC g918233g05h01.jpg GRAPHIC 149398
  Complete submission text file 0001193125-25-006124.txt   8046783

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kymr-20250114.xsd EX-101.SCH 2854
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kymr-20250114_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kymr-20250114_pre.xml EX-101.PRE 11264
45 EXTRACTED XBRL INSTANCE DOCUMENT d918233d8k_htm.xml XML 3646
Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39460 | Film No.: 25529381
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)